Login / Signup

Adjunctive intravenous immunoglobulins (IVIg) for moderate-severe COVID-19: emerging therapeutic roles.

Felix BongominLucy Grace AsioKenneth SsebambuliddeJoseph Baruch Baluku
Published in: Current medical research and opinion (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • high dose
  • high intensity
  • early onset
  • respiratory syndrome coronavirus
  • low dose